FMI’s analysis reveals promising prospects for the Global Dengue Vaccines Industry, expecting substantial advancements that could propel it beyond US$ 1603.7 million by 2033. The forecast indicates a robust double-digit CAGR throughout the envisaged period. With key pharmaceutical companies concluding clinical trials, analyst express optimism about potential new product launches, significantly expanding the growth horizon. …
Tag Archives: Dengue Vaccines
Embracing a Brighter Future: Dengue Vaccines Market Set to Reach US$ 1.6 Billion by 2033 with a Striking 12.9% CAGR
The rising prevalence of dengue fever in the Asia-Pacific region has increased demand for effective medicines and vaccines to combat this viral disease. While some pharmaceutical companies are focusing on developing a dengue vaccine, the rate of dengue in the Asia-Pacific region is rapidly increasing. According to a Future Market Insights (FMI) report, the Asia-Pacific …